Strategic Initiative

Slingshot members are tracking this corporate initiative:

Sanofi (SNY) and Alnylam (ALNY) Agree to Co-Develop and Commercialize RNAi Therapeutic Fitusiran in Treatment of Hemophilia and Rare Bleeding Disorders

Source Link:: http://investors.alnylam.com/releasedetail.cfm?ReleaseID=999180

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies

Importance

High

Medium

Low

Impact on Stocks

SNY

100%

ALNY

100%

SIGN ME UP
I want to vote! LOG ME IN
Now!

Slingshot Insights Explained

JOIN FOR FREE TODAY

Strategic Initiative Date

Announcement Date:

Nov 14, 2016

Projected Implementation:

Q1, 2017

Relevance Tracked Until:

Q1, 2019

Related Projects

Don’t see a project related to the strategic initiative you care about?

Related Keywords Development, Commercialization, Fitusiran, Hemophilia, Rare Bleeding Disorders